Your browser doesn't support javascript.
loading
Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin.
Smith, Susan H; Peredo, Carlos E; Takeda, Yukimasa; Bui, Thi; Neil, Jessica; Rickard, David; Millerman, Elizabeth; Therrien, Jean-Philippe; Nicodeme, Edwige; Brusq, Jean-Marie; Birault, Veronique; Viviani, Fabrice; Hofland, Hans; Jetten, Anton M; Cote-Sierra, Javier.
Afiliación
  • Smith SH; Discovery and Preclinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America.
  • Peredo CE; Discovery and Preclinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America.
  • Takeda Y; Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, United States of America.
  • Bui T; Discovery and Preclinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America.
  • Neil J; Discovery and Preclinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America.
  • Rickard D; MDR/PTS, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America.
  • Millerman E; Discovery and Preclinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America.
  • Therrien JP; Discovery and Preclinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America.
  • Nicodeme E; Flexible Discovery Unit, GlaxoSmithKline, Les Ulis Cedex, France.
  • Brusq JM; Flexible Discovery Unit, GlaxoSmithKline, Les Ulis Cedex, France.
  • Birault V; Respiratory Therapeutic Area, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, United Kingdom.
  • Viviani F; Flexible Discovery Unit, GlaxoSmithKline, Les Ulis Cedex, France.
  • Hofland H; Discovery and Preclinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America.
  • Jetten AM; Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, United States of America.
  • Cote-Sierra J; Discovery and Preclinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America.
PLoS One ; 11(2): e0147979, 2016.
Article en En | MEDLINE | ID: mdl-26870941
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_geracao_evidencia_conhecimento Asunto principal: Psoriasis / Piel / Interleucina-17 / Bibliotecas de Moléculas Pequeñas / Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares / Factores Inmunológicos Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_geracao_evidencia_conhecimento Asunto principal: Psoriasis / Piel / Interleucina-17 / Bibliotecas de Moléculas Pequeñas / Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares / Factores Inmunológicos Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos